AC Immune (ACIU) Accumulated Expenses (2015 - 2025)

AC Immune (ACIU) has 11 years of Accumulated Expenses data on file, last reported at $10.1 million in Q4 2025.

• Quarterly Accumulated Expenses fell 26.91% year-over-year to $10.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.1 million (down 26.91% YoY) and the FY2025 annual result came in at $9.7 million, down 29.55% from the prior year.
• Accumulated Expenses slipped to $10.1 million in Q4 2025 per ACIU's latest filing, from $15.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $18.2 billion in Q4 2021 and bottomed at $9.4 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $12.8 million (2025), against an average of $3.4 billion.
• The widest annual swing landed in 2021, when Accumulated Expenses jumped 147923.32%; it then sank 99.95% in 2022.
• Tracing ACIU's Accumulated Expenses over 5 years: stood at $18.2 billion in 2021, then slumped by 99.95% to $9.8 million in 2022, then surged by 127766.11% to $12.5 billion in 2023, then slumped by 99.89% to $13.8 million in 2024, then declined by 26.91% to $10.1 million in 2025.
• Per Business Quant, the three latest ACIU Accumulated Expenses figures stand at $10.1 million (Q4 2025), $15.0 million (Q3 2025), and $13.9 million (Q2 2025).

Peer Comparison